World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
65275
World Ranking
4456
National Ranking
2428

Overview

John H. Stone is affiliated with Harvard University in the United States. Their research primarily spans the field of Medicine with a strong focus on Rheumatology, Pulmonary and Respiratory Medicine, Genetics, Surgery, and Epidemiology.

The scientist has contributed to various topics within medical research, including:

  • Vasculitis and related conditions
  • IgG4-Related and Inflammatory Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Neuroendocrine Tumor Research Advances
  • Gastrointestinal disorders and treatments
  • Otitis Media and Relapsing Polychondritis
  • Urticaria and Related Conditions

John H. Stone's publication record includes numerous papers in prominent journals. Some recent significant works are:

  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19, 2020, New England Journal of Medicine
  • 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, 2021, Arthritis & Rheumatology
  • 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis, 2021, Arthritis & Rheumatology
  • IgG4-related disease: an update on pathophysiology and implications for clinical care, 2020, Nature Reviews Rheumatology
  • 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, 2021, Arthritis Care & Research

The scientist's frequent collaboration includes working with various researchers, notably:

  • Zachary S. Wallace
  • Cory A. Perugino
  • Peter A. Merkel
  • Hyon K. Choi
  • Xiaoqing Fu

John H. Stone has published extensively in several key venues with notable publication counts in:

  • Annals of the Rheumatic Diseases (26 publications)
  • Seminars in Arthritis and Rheumatism (14 publications)
  • The Lancet Rheumatology (10 publications)
  • Arthritis & Rheumatology (9 publications)
  • Arthritis Care & Research (9 publications)

In addition to journal articles, John H. Stone has authored a book titled Pandemic Cities, published by Springer Nature in 2022.

Best Publications

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu

  • Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo

  • IgG4-related disease.

    Stone Jh;Zen Y;Deshpande

  • Consensus statement on the pathology of IgG4-related disease

    Vikram Deshpande;Yoh Zen;John Kc Chan;Eunhee E Yi

  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.

    John H. Stone;Matthew J. Frigault;Naomi J. Serling-Boyd;Ana D. Fernandes

  • Trial of Tocilizumab in Giant-Cell Arteritis.

    John H Stone;Katie Tuckwell;Sophie Dimonaco;Micki Klearman

  • IgG4-related disease

    Terumi Kamisawa;Yoh Zen;Shiv Pillai;John H Stone

  • Revised international Chapel Hill consensus conference nomenclature of vasculitides

    J. C. Jennette;R. J. Falk;P. Bacon;N Basu

  • International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease

    A. Khosroshahi;Z. S. Wallace;J. L. Crowe;T. Akamizu

  • Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis

    Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera

  • IgG4-Related Disease

    John H. Stone;John K. C. Chan;Vikram Deshpande;Kazuichi Okazaki

  • The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

    Zachary S. Wallace;Ray P. Naden;Suresh Chari;Hyon K. Choi

  • Rituximab for IgG4-related disease: a prospective, open-label trial

    Mollie N Carruthers;Mark D Topazian;Arezou Khosroshahi;Thomas E Witzig

  • IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.

    Zachary S. Wallace;Vikram Deshpande;Hamid Mattoo;Vinay S. Mahajan

  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin

  • Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.

    Arezou Khosroshahi;Donald B. Bloch;Vikram Deshpande;John H. Stone

  • Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial

    Gary S. Hoffman;Maria C. Cid;Karen E. Rendt-Zagar;Peter A. Merkel

  • Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations

    John H. Stone;Arezou Khosroshahi;Vikram Deshpande;John K. C. Chan

  • Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.

    Arezou Khosroshahi;Mollie N. Carruthers;Vikram Deshpande;Sebastian Unizony

  • The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.

    Zachary S Wallace;Ray P Naden;Suresh Chari;Hyon Choi

Frequent Co-Authors

Ulrich Specks
Ulrich Specks Mayo Clinic
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
E. William St. Clair
E. William St. Clair Duke University
Vikram Deshpande
Vikram Deshpande Harvard University
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Hyon K. Choi
Hyon K. Choi Harvard Medical School
Alfred Mahr
Alfred Mahr Université Paris Cité
Maria C. Cid
Maria C. Cid University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine and healthcare in the USA isn’t limited to traditional paths. Various online rn-bsn programs without clinicals are now available, making it easier for working nurses to advance their qualifications. These accessible RN to BSN options are ideal for those balancing work, family, and studies.

Ambitious nurses seeking advanced practice roles or leadership positions can explore accelerated dnp programs online. These programs offer condensed timelines, letting experienced registered nurses move quickly from the classroom to high-level practice.

For those seeking less-intensive research demands, there are also online dnp programs without dissertation. This pathway allows professionals to focus more on practical skills and clinical leadership, rather than lengthy academic research.

Entry-level students or career changers looking to step into the healthcare field quickly may be interested in a 6 month lpn program online. These fast-track LPN options can start you on a nursing career in less than a year.

Best Scientists Citing John H. Stone

Trending Scientists

Recently Published Articles